The AI-powered B2B partnering hub for Pharmaceutical Executives. Publish and discover Innovative assets, Biosimilars, Value Added Products (VAPs), Generics, and Specialized Services across Human and Animal Health as anonymized Blind Profiles — and connect directly with verified decision-makers globally, 365 days a year.
Matchmaker Overlap
High SynergyRegulatory match: Zone IV
GMP alignment: 100%
You matched in the Matchmaker. You can now continue your conversation here.
Adalimumab is a pharmaceutical asset presented in a pre-filled syringe formulation at a strength of 40 mg for auto-immune diseases.
Core value
Every capability is built around confidential evaluation, anonymous portfolio presentation, and mutual-interest dealmaking.
Connect directly with verified decision-makers globally. Post your licensing or service requirements and get feedback from multiple qualified partners across products and specialized services — no intermediary friction, no brokerage fees, and no cold outreach reaching your inbox.
Access a structured catalogue of ready-to-license assets across all clinical phases to commercialized products, alongside specialized value-adding pharma services in both human and animal health — searchable through multi-select ATC (Levels 1–5) and NFC (Levels 1–3) taxonomies rather than broad keywords.
Seamlessly source and license Innovative pharmaceuticals, Biosimilars, Value Added Products (VAPs), and Generics across both Human Health and Animal Health (Veterinary) sectors, spanning commercial and clinical pipeline stages — each presented as an anonymized Blind Profile.
Accelerate portfolio development and expand your partner network efficiently: run Digital Partnering Sprints ahead of major industry events like CPhI Milan 2026, then keep those conversations alive for the other 362 days of the year.
Pricing
1IBHub membership costs €299 per year — a single flat fee that covers the entire platform. There are no per-listing charges, no success fees, no brokerage commissions and no hidden costs. Whether you close one deal or fifty, your cost stays the same: €299 a year, all-inclusive.
Full access to every feature, for every member — no tiers locked behind upgrades.
Compared to a single 2–3 day partnering conference ticket plus travel, one year of 1IBHub pays for itself many times over.
Executive Deck
Swipe through our executive presentation or download the PDF to share directly with your Business Development team.
Download the presentation deck (PDF) to review offline or share directly with your Business Development colleagues.
Pharma Marketplace
Filter by therapeutic area, dosage form, regulatory status, dossier type and target territory. Each listing carries the technical and commercial data your evaluation committee needs before the first call.
Solutions
Browse anonymous listings for products (from early clinical phases to commercial assets) and specialized pharma services across human and animal health. Filter by target markets, therapeutic area, and phase — or let the AI Matchmaker surface aligned counterparties from your own criteria — then send confidential contact requests directly to offering parties.
Publish your product portfolio and specialized services 100% anonymously as Blind Profiles. Define specific market availabilities and stay in full control—your identity is revealed only when you choose to accept a contact request.
Cut out cold outreach and intermediary fees. Engage exclusively with genuinely interested, verified counterparties through mutual-interest matchmaking, streamlined deal-making, and secure direct platform chat — with zero brokerage fees on resulting deals.
How it works
Pharmaceutical business development is slowed down by two things: confidentiality concerns and unsolicited outreach. 1IBHub removes both — every product and service listing stays an anonymous Blind Profile until mutual interest is confirmed, and structured taxonomies replace broad keyword searching. The result is four steps that work every day of the year, not only during a 2-to-3-day event window.
Publish Rx, OTC, clinical, commercial assets, or specialized pharma services as anonymized Blind Profiles. Specify therapeutic areas, formulation types, or service categories, and select target markets across human and animal health.
Platform advantage
Tag each listing as an Out-Licensing Asset, In-Licensing Mandate, CMO / Contract Manufacturing opportunity, or Specialized Service — so mandated buyers find it without asking who you are.
In-licensing and procurement managers filter anonymous listings by therapeutic area, development phase, service type, formulation, and target territory to find exact strategic fits in minutes.
Platform advantage
Radical segmentation through multi-select ATC Levels 1–5 and NFC Levels 1–3 replaces broad keyword scanning and compresses sourcing timelines across Generics, VAPs, OTC, and Services.
Submit a contact request on an anonymous listing or let the AI Matchmaker surface aligned counterparties from the criteria you define. Following a strict double opt-in principle, no contact details or company names are revealed until the offering party accepts.
Platform advantage
Source continuously and run focused Partnering Weeks ahead of major industry gatherings to maximize concurrent online activity and pre-book meetings before anyone travels.
Once the request is accepted, both parties connect instantly on the platform. Open a secure chat thread to exchange dossiers, service proposals, and term sheets to advance cross-border deals.
Platform advantage
Move from a qualified match to a direct executive conversation inside secure chat without leaving the ecosystem.
FAQ
The questions business development teams ask most often about products, specialized services, confidentiality, and direct partnering across human and animal health.
Share 1IBHub with your BD network
Have questions regarding B2B licensing or early platform access? Send us a direct message.